ImmunoBrain Checkpoint awarded Alzheimer’s Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer’s disease

ImmunoBrain Checkpoint awarded Alzheimer’s Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer’s disease NEW YORK, Tuesday September 1, 2020 – ImmunoBrain Checkpoint Inc. (“IBC”) announced today that it has been awarded a $1,000,000 grant from the Alzheimer’s Association under the 2020 Part the Cloud-Bill Gates Partnership Grant Program to […]

Read More

Intuitive, integrated and efficient – world premiere of Philips’ next-generation Azurion image-guided therapy platform

September 1, 2020 New level of integration across imaging, physiology, hemodynamic and informatics applications SmartCT guides acquisition of 3D CT-like images and provides visualization and measurement tools Increased efficiency and flexibility with tableside access to more modalities and intuitive control of the gantry Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global […]

Read More